Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 45: | Line 45: | ||
* [[Abemaciclib]] - brand name [[Verzenio]] | * [[Abemaciclib]] - brand name [[Verzenio]] | ||
* [[Ribociclib]] - brand name [[Kisqali]] | * [[Ribociclib]] - brand name [[Kisqali]] | ||
| + | |||
| + | See also [[Anti-cancer drugs]] and [[Anticancer drugs]] | ||
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
__NOTOC__ | __NOTOC__ | ||
Revision as of 10:46, 6 January 2025
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
ChemotherapyDihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitors
Estrogen Receptor Modulator
mTOR inhibitor
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitors
Vascular Endothelial Growth Factor Inhibitor
Poly ADP ribose polymerase (PARP) inhibitorsCyclin-dependent kinases inhibitors
See also Anti-cancer drugs and Anticancer drugs |
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
